|
[an error occurred while processing this directive]
|
Item #5
New
Stem Cell Technology to Develop Diabetes Treatment
Technology
to use GLP-1 to make stem cells into beta cells.
Boston-based
ViaCell Inc. announced Monday plans to use its stem cell technology to
develop a treatment for diabetes.
The
company announced its plans on the heels of a report by researchers
from Massachusetts General Hospital who used a hormone from a
patient's intestine, called glucagon-like peptide-1, that appears to
make stem cells into insulin-producing cells.
The
hormone transformed islet stem cells into insulin-producing
pancreatic-beta cells, details of which will be reported in the August
issue of the journal Endocrinology.
The
company will be doing preclinical work on a few different approaches
at treating diabetes with stem cells, and possibly even the MGH
method. The company will be using stem cells from pancreatic islets,
umbilical cord blood and bone marrow, among others.
Snoring
increases diabetes risk.
A recent study in the American
Journal of Epidemiology Vol. 155, No. 5 : 387-393 indicated
that snoring was an independent risk factor in the eventual
diagnosis of diabetes. In addition irregular sleep patterns have
been associated with hormonal imbalance, possibly affecting fasting
glucose values. If you have diabetes and live with a snorer, your
interrupted sleep patterns can affect your glucose as well.
Read
The Effects of Snoring on Diabetes Patients,
by Keith Campbell, RPh, FASHP, FAPhA, CDE
[an error occurred while processing this directive]
|
[an error occurred while processing this directive]
|
